Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

University of California develops anti-alphavbeta1 integrin inhibitors

Sep. 28, 2016

NIH grants support work at Feinstein Institute on bioelectronic medicine and sepsis

Aug. 19, 2016

Hutchison MediPharma patents PI3K inhibitors

Aug. 18, 2016

SAMD9 mutations cause new form of syndromic adrenal hypoplasia

July 29, 2016

InflaRx raises funds in series C financing

July 25, 2016

Mutations in TRMT10C identified as a cause of mitochondrial disease

July 15, 2016

Animal model studies give insight into mechanisms of disease

June 6, 2016

Bayer Schering Pharma patents factor XIa and KLKB1 inhibitors

April 7, 2016

p53 might be useful to distinguish Langerhans cell hyperplasia from Langerhans cell histiocytosis

March 10, 2016

Acetazolamide counters effects of Klotho hypomorphism on aging

Jan. 20, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...